ethambutol has been researched along with clofazimine in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (8.82) | 18.7374 |
1990's | 32 (47.06) | 18.2507 |
2000's | 9 (13.24) | 29.6817 |
2010's | 18 (26.47) | 24.3611 |
2020's | 3 (4.41) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Aínsa, JA; Martín, C; Ramón-García, S; Thompson, CJ | 1 |
Barry, CE; Dartois, V | 1 |
Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
Boido, V; Cannas, S; Loddo, R; Molicotti, P; Novelli, F; Parapini, S; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Zanetti, S | 1 |
Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J | 1 |
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Sychra, P; Valášková, L; Vávrová, K; Vlčková, H | 1 |
Bera, S; Mondal, D | 1 |
Dušek, J; Hrabálek, A; Huszár, S; Jand'ourek, O; Karabanovich, G; Klimešová, V; Kočová Vlčková, H; Konečná, K; Konyariková, Z; Korábečný, J; Korduláková, J; Kučera, T; Mikušová, K; Pávek, P; Pávková, I; Pavliš, O; Roh, J; Savková, K; Stolaříková, J; Vávrová, K | 1 |
Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
Dautzenberg, B; Grosset, J; Katlama, C; Mignon, A; Parrot, R; Perronne, C; Rozenbaum, W; Truffot, C | 1 |
Bartok, AE; Chiu, J; Deresinski, SC; Feigal, DF; Kemper, CA; Leedom, JM; McCutchan, JA; Meng, TC; Nussbaum, J; Tilles, JG | 1 |
Benson, CA; Kessler, HA; Pottage, JC; Trenholme, GM | 1 |
Dwyer, B; Grayson, L; Hoy, J; Lucas, R; Mijch, A; Sandland, M | 1 |
Saito, H; Sato, K | 1 |
Blanche, S; Bodemer, C; De Prost, Y; Durand, C; Teillac, D | 1 |
Gharpuray, MB; Kulkarni, DS; Kulkarni, V | 1 |
Agins, BD; Berman, DS; el-Sadr, W; Rahal, JJ; Simberkoff, MS; Spicehandler, D | 1 |
Farhi, DC; Gangadharam, PR; Iseman, MD; Jairam, BT; Nguyen, AK; Perumal, VK; Rao, PN | 1 |
Nash, DR; Steele, LC; Steingrube, V; Wallace, RJ | 1 |
De Micco, P; Gevaudan, MJ | 1 |
Dekio, S; Hidaka, T; Kawahara, S; Saito, H; Sato, K; Tomioka, H | 1 |
Gordin, FM; Sullam, PM; Wynne, BA | 1 |
Dautzenberg, B; Olliaro, P | 1 |
Bartok, AE; Dubé, M; Haghighat, D; Havlir, D; Kemper, CA; Leedom, JM; Sison, JP; Tilles, JG; Yangco, B; Yao, Y | 1 |
Bartok, AE; Camp, B; Deresinski, SC; Havlir, D; Kane, C; Kemper, CA; Lane, N | 1 |
Bryskier, A; Goh, KS; Rastogi, N | 1 |
Andreoli, A; Kohn, A; Luzi, C; Mangiarotti, R; Prantera, C | 1 |
Gordon, SM; Havlik, JA; Heifets, L; Horsburgh, CR; McGowan, JE; Metchock, B; Peloquin, CA; Thompson, SE | 1 |
Brummer, E; Deresinski, SC; Hamilton, JR; Kemper, CA; Sison, JP; Stevens, DA; Yao, Y | 2 |
Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
Carosi, GP; Dautzenberg, B; Esposito, R; Hoy, JF; L'Age, M; Micoud, M; Olliaro, P; Opravil, M; Pirotta, N; Rozenbaum, W; Ruf, B; Sassella, D | 1 |
Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
Bryskier, A; Devallois, A; Goh, KS; Rastogi, N | 1 |
Benson, CA; Chaisson, RE; Craft, JC; Fessel, WJ; Keiser, P; Lahart, C; Meek, K; Pierce, M; Ruskin, J; Siepman, N | 1 |
Beuscart, C; Brel, F; Dautzenberg, B; Doco-Lecompte, T; Grosset, J; May, T; Perronne, C; Saint-Marc, T; Vincent, V | 1 |
Butts, JD; Faris, MA; Hopfer, RL; Raasch, RH | 1 |
Barber, TW; Currier, J; Ellner, JJ; Hafner, R; Hojczyk, P; Hooton, TM; Jacobs, MR; Limjoco, M; Parenti, DM; Powderly, WG; Simpson, G; van der Horst, C; Williams, PL | 1 |
Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ | 1 |
Burguière, AM; Eliaszewicz, M; Flahault, A; Fournier, S; Treilhou, MP; Vincent, V | 1 |
Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
Cheng, B | 1 |
Prescott, LM | 1 |
Currier, J | 1 |
Cocco, MT; Congiu, C; De Logu, A; Onnis, V; Saddi, B; Schivo, ML | 1 |
Cowie, RL; Field, SK | 1 |
Janulionis, E; Sofer, C; Song, HY; Wallis, RS | 1 |
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
Agnihotri, SP; Gupta, P; Gupta, S; Jain, NK; Sharma, KK | 1 |
Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
Chiang, CY; Madan, J; Meredith, SK; Nunn, AJ; Phillips, PP; Rusen, ID; Squire, SB; Torrea, G; Van Deun, A | 1 |
Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A | 1 |
Abena Foe, JL; Aït-Khaled, N; Kuaban, C; Noeske, J; Rieder, HL; Trébucq, A | 1 |
Cowie, RL; Davis, JP; Field, SK; Fisher, DA; Jarand, J | 1 |
Adamson, J; Almeida, DV; Ammerman, NC; Bester, LA; Dorasamy, A; Grosset, JH; Mgaga, Z; Moodley, C; Moodley, S; Ngcobo, B; Singh, SD; Swanson, RV | 1 |
Chande, N; MacDonald, JK; Parker, CE; Patton, PH | 1 |
Blackmore, T; McNaughton, A; McNaughton, H | 1 |
Cao, P; Doan, TN; Emeto, TI; McBryde, ES; McCaw, JM | 1 |
Ding, X; Fan, G; Ho, CM; Jiang, J; Lan, L; Lou, Y; Wu, S | 1 |
Chaudhary, S; Garg, V; Maji, S; Singh, V | 1 |
Ahmad, N; Atif, M; Ghafoor, A; Iqbal, Q; Khan, S; Latif, A; Saleem, F; Wahid, A | 1 |
Anderson, R; Cholo, MC; Mashele, SA; Matjokotja, MT; Rasehlo, SSM; Steel, HC | 1 |
4 review(s) available for ethambutol and clofazimine
Article | Year |
---|---|
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Lung; Mycobacterium tuberculosis; Tuberculosis | 2013 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals.
Topics: 4-Quinolones; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clofazimine; Ethambutol; Humans; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifamycins | 1998 |
Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Crohn Disease; Ethambutol; Glucocorticoids; Humans; Maintenance Chemotherapy; Methylprednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rifabutin; Rifampin; Secondary Prevention | 2016 |
18 trial(s) available for ethambutol and clofazimine
Article | Year |
---|---|
Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium Infections; Opportunistic Infections; Prospective Studies; Rifabutin; Rifamycins | 1991 |
Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amikacin; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin | 1992 |
Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Bacteremia; Clofazimine; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin | 1994 |
Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: a prospective trial with rifabutin combined with isoniazid, clofazimine, ethambutol.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Body Burden; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Quality of Life; Rifabutin | 1994 |
The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clofazimine; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin | 1994 |
Transient bacteremia due to Mycobacterium avium complex in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Life Tables; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence; Rifampin; Risk Factors; Survival Analysis | 1994 |
Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Crohn Disease; Dapsone; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Prospective Studies; Rifampin; Time Factors | 1994 |
Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Bacteremia; Clofazimine; Ethambutol; Humans; In Vitro Techniques; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1996 |
Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?
Topics: AIDS-Related Opportunistic Infections; Animals; Antitubercular Agents; Clofazimine; Colony Count, Microbial; Disease Models, Animal; Ethambutol; Humans; Liver; Mice; Mycobacterium avium-intracellulare Infection; Rifampin; Species Specificity; Spleen | 1996 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antitubercular; Antitubercular Agents; Clofazimine; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium Infections; Placebos; Rifabutin | 1996 |
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection | 1997 |
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence; Rifabutin | 1997 |
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1998 |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1999 |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
Topics: Aged; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis | 1999 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
Topics: Antitubercular Agents; Bangladesh; Clinical Protocols; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Moxifloxacin; Prothionamide; Pyrazinamide; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
46 other study(ies) available for ethambutol and clofazimine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Clofazimine; Dithiothreitol; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutathione; Hydrogen Peroxide; Membrane Transport Proteins; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rifampin; Valinomycin | 2009 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Phenazines; Pyrrolidines; Quinolizidines; Structure-Activity Relationship; Tuberculosis; Vero Cells | 2014 |
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
Topics: Antitubercular Agents; Caco-2 Cells; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Solubility; Structure-Activity Relationship; Tetrazoles; Water | 2017 |
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Dinitrobenzenes; Dose-Response Relationship, Drug; Drug Development; Hydrocarbons, Fluorinated; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2019 |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin | 1991 |
Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifamycins; Sepsis | 1990 |
Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice.
Topics: Animals; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Kanamycin; Liver; Lung; Mice; Mice, Inbred C57BL; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifamycins; Spleen | 1989 |
[Disseminated Mycobacterium marinum infection].
Topics: Child, Preschool; Clofazimine; Consanguinity; Drug Therapy, Combination; Ethambutol; Female; Hepatomegaly; Humans; Immunity, Cellular; Joint Diseases; Mycobacterium Infections; Rifampin; Skin Diseases; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
Topics: Abscess; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethambutol; Hip Joint; Humans; Isoniazid; Leprosy, Borderline; Leprosy, Lepromatous; Male; Rifampin; Tuberculosis, Osteoarticular | 1989 |
Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Lactams, Macrocyclic; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Respiratory Tract Infections; Retrospective Studies; Sepsis | 1989 |
Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections.
Topics: Animals; Chronic Disease; Clofazimine; Drug Therapy, Combination; Ethambutol; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifabutin; Rifamycins; Tuberculosis | 1987 |
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Topics: Anti-Bacterial Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Streptomycin; Sulfamethoxazole | 1986 |
[Extra and intracellular activity of dirithromycin against Mycobacterium avium].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Ethambutol; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Macrolides; Macrophages; Mycobacterium avium; Rifabutin | 1995 |
Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rifamycins; Streptomycin | 1995 |
Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
Topics: Amikacin; Clofazimine; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin | 1994 |
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
Topics: Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Drug Monitoring; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin | 1993 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clofazimine; Drug Combinations; Ethambutol; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin | 1996 |
Advances in prevention and treatment of MAC.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Clinical Trials as Topic; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin | 1995 |
Macrolides, azalides, and streptogrammins.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin | 1996 |
Progress report: prophylaxis and therapy for MAC.
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Pot shots.
Topics: Acetylcysteine; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Antiviral Agents; Cattle; CD4 Lymphocyte Count; China; Clarithromycin; Clinical Trials as Topic; Clofazimine; Cryptosporidiosis; Drug Combinations; Ethambutol; Expectorants; Glutathione; Hepatitis B; Humans; Immunoglobulins; Interferon-alpha; Italy; Leprostatic Agents; Mycobacterium avium-intracellulare Infection; Philippines; Protease Inhibitors; Survival Rate; Taiwan; Thymosin; Zidovudine | 1996 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine | 1996 |
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
Topics: Aminosalicylic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Chlorocebus aethiops; Clofazimine; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Hydrazones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Vero Cells | 2002 |
Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine.
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Leprostatic Agents; Lung Diseases; Macrolides; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 2003 |
Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture.
Topics: Anti-Infective Agents; Antitubercular Agents; Area Under Curve; Blood; Cells, Cultured; Clofazimine; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Serum Bactericidal Test | 2004 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
Extensively drug resistance (XDR) tb is not always fatal.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Capreomycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Injections; Male; Moxifloxacin; Quinolines; Sputum; Treatment Outcome | 2009 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.
Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cameroon; Clofazimine; Cohort Studies; Confidence Intervals; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Kanamycin; Male; Medication Adherence; Middle Aged; Odds Ratio; Prospective Studies; Prothionamide; Pyrazinamide; Risk Assessment; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia; Retrospective Studies; Rifampin | 2016 |
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Topics: Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Withholding Treatment | 2016 |
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2016 |
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Topics: Antitubercular Agents; Clofazimine; Colony Count, Microbial; Computer Simulation; Diarylquinolines; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Host-Pathogen Interactions; Humans; Immunity, Innate; Isoniazid; Kanamycin; Macrophages; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Pyrazinamide; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Simultaneous determination of the potent anti-tuberculosis regimen-Pyrazinamide, ethambutol, protionamide, clofazimine in beagle dog plasma using LC-MS/MS method coupled with 96-well format plate.
Topics: Animals; Antitubercular Agents; Calibration; Chromatography, Liquid; Clofazimine; Dogs; Ethambutol; Prothionamide; Pyrazinamide; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Isolated multidrug-resistant tubercular tenosynovitis of the flexor tendon of the little finger.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Resistance, Multiple; Ethambutol; Female; Fingers; Humans; Levofloxacin; Linezolid; Magnetic Resonance Imaging; Tendons; Tenosynovitis; Tuberculosis; Young Adult | 2021 |
Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review.
Topics: Adult; Amikacin; Antitubercular Agents; Clofazimine; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Lost to Follow-Up; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Retrospective Studies; Survival Analysis; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2021 |
Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro.
Topics: Animals; Antitubercular Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2022 |